1Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group. Transplantation, 1995, 60:225-232.
2European Mycophenolate Mofetil Cooperative Study Group. Placebocontrolled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet, 1995, 345:1321-1325.
3The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation, 1996, 61 : 1029 - 1037.
4Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet, 1998, 34:429 - 455.
5Jeong H, Kaplan B. Theapeutic monitoring of mycophenolate mofetil. Clin J Am Sac Nephrol, 2007, 2:184 - 191.
6Schutz E, Shipkova M, Armstrong VW, et al. Therapeutic drug monitoring of mycophenolic acid : Comparison of HPLC and immunoassay reveals new MPA metabolites. Transplant Proc, 1998, 30:1185 - 1187.
7Kobayashi M, Saitoh H, Tadano K, et al. Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by muhidmg resistance-associated protein 2 in rats. J Pharmacol Exp Ther, 2004, 309:1029 - 1035.
9Bullingham RE, Nicholls A, Hale M. Pharmacokinetics of mycophenolate mofetil (RS61443) : A short review. Transplant Proc, 1996, 28 : 925 - 929.
10Nowak I, Shaw LM. Mycophenolic acid binding to human serum albumin: Characterization and relation to pharmacodynamics. Clin Chem, 1995,41: 1011- 1017.
4Shin J,Park J,Shin Y,et al.Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children? Pediatr Nephrol,2005,20(8):1087-1092.
5Hu WX,Liu ZH,Chen HP,et al.Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.Chin Med J,2002,115(5):705-709.
6Mills JA,Michel BA,Bloch DA,et al.The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura.Arthritis Rheum,1990,33(8):1114-1121.
7Ronkainen J,Nuutinen M,Koskimies O,et al.The adult kidney 24 years after childhood Henoch-Schonlein purpura:a retrospective cohort study.Lancet,2002,360(9334):666-670.
8Pillebout E,Thervet E,Hill G,et al.Henoch-Schonlein Purpura in adults:outcome and prognostic factors.J Am Soc Nephrol,2002,13(5):1271-1278.
9Iijima K,Ito-Kariya S,Nakamura H,et al.Multiple combined therapy for severe Henoch-Scholein nephritis in children.Pediatr Nephrol,1998,12 (3):244-248.
10Kawasaki Y,Suzuki J,Nozawa R,et al.Efficacy of Methylprednisolone and Urokinase Pulse Therapy for Severe Henoch-Schonlein Nephritis Pediatrics,2003,111 (4 Pt 1):785-789.
